SCHEMBL3904606

SCHEMBL3904606

CCCCCC[B-](c1cccc(F)c1)(c1cccc(F)c1)c1cccc(F)c1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.43
TLR8 Q9NR97 1/20 0.39
GRM2 Q14416 1/20 0.36
GCGR P47871 1/20 0.36
ICMT O60725 3/20 0.36
ACHE P22303 1/20 0.35
LPL P06858 1/20 0.35
LIPG Q9Y5X9 1/20 0.35
KCNH2 Q12809 2/20 0.34
CNR2 P34972 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31145657 1.00 MGLL (0.43) MGLLTLR8GRM2GCGRICMT
SCHEMBL31741939 0.98 MGLL (0.42) MGLLTLR8GRM2GCGRICMT
Tetramethylammonium Ion SCHEMBL7662067 0.95 MGLL (0.40) MGLLTLR8GRM2GCGRICMT
SCHEMBL4961254 0.93 MGLL (0.39) MGLLTLR8GRM2GCGRACHE
SCHEMBL26327147 0.92 ACHE (0.46) MGLLTLR8GRM2GCGRICMT
Tetrabuthylammonium SCHEMBL809813 0.92 MGLL (0.39) MGLLTLR8GRM2GCGRICMT
Lithium Ion SCHEMBL6289526 0.91 MGLL (0.38) MGLLTLR8GRM2GCGRICMT
SCHEMBL26287032 0.91 MGLL (0.38) MGLLTLR8MEN1ALDH1A1KMT2A
SCHEMBL26287029 0.91 MGLL (0.38) MGLLTLR8MEN1ALDH1A1KMT2A
SCHEMBL31145634 0.90 MGLL (0.38) MGLLTLR8GRM2GCGRICMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943287-A2 MOLDING COMPOSITION AND METHOD, AND MOLDED ARTICLE General Electric Company (US) 2008-07-16 EP claimed
US-7378455-B2 A curable epoxy resin , two latent cationic curing catalyst, a free radical-producng cocatalyst and inorganic filler of about 70-95 weight % based on the total weight; catalyst allows the use of increased filler loadingsto reduce moisture absorption and thermal expansion; encapsulating solid state device GENERAL ELECTRIC COMPANY (US) 2008-05-27 US claimed
WO-2007005280-A2 MOLDING COMPOSITION AND METHOD, AND MOLDED ARTICLE GENERAL ELECTRIC COMPANY (US) 2007-01-11 WO claimed
US-20070004819-A1 A curable epoxy resin , two latent cationic curing catalyst, a free radical-producng cocatalyst and inorganic filler of about 70-95 weight % based on the total weight; catalyst allows the use of increased filler loadingsto reduce moisture absorption and thermal expansion; encapsulating solid state device CITIBANK, N.A., AS COLLATERAL AGENT 2007-01-04 US claimed
EP-4043502-B1 PHOTOPOLYMERIZABLE HOE COMPOSITION XETOS AG (DE) 2023-10-04 EP disclosed
WO-2023156484-A1 PHOTOPOLYMER COMPOSITIONS FOR THERMOSTABLE PHOTOPOLYMERS IN THE VISIBLE SPECTRAL RANGE COVESTRO DEUTSCHLAND AG (DE) 2023-08-24 WO disclosed
EP-4043961-B1 2K SYSTEM XETOS AG (DE) 2023-08-16 EP disclosed
US-10813831-B2 Medical bathing device BSN MEDICAL GMBH (DE) 2020-10-27 US disclosed
US-20180153768-A1 MEDICAL BATHING DEVICE BSN MEDICAL GMBH (DE) 2018-06-07 US disclosed
US-20180153768-A1 MEDICAL BATHING DEVICE BSN MEDICAL GMBH (DE) 2018-06-07 US disclosed
US-20180116920-A1 MULTI-STEP PROCESS FOR NO PRODUCTION BSN MEDICAL GMBH (DE) 2018-05-03 US disclosed
US-20180116920-A1 MULTI-STEP PROCESS FOR NO PRODUCTION BSN MEDICAL GMBH (DE) 2018-05-03 US disclosed
WO-2001096962-A2 MULTIPHOTON ABSORPTION METHOD USING PATTERNED LIGHT 3M INNOVATIVE PROPERTIES COMPANY (US) 2001-12-20 WO disclosed
WO-2001096959-A2 MULTIDIRECTIONAL PHOTOREACTIVE ABSORPTION METHOD 3M INNOVATIVE PROPERTIES COMPANY (US) 2001-12-20 WO disclosed
WO-2001096961-A2 MULTIPASS MULTIPHOTON ABSORPTION METHOD AND APPARATUS 3M INNOVATIVE PROPERTIES COMPANY (US) 2001-12-20 WO disclosed
WO-2001092024-A2 IMAGING MEDIA CONTAINING HEAT DEVELOPABLE PHOTOSENSITIVE MICROCAPSULES SIPIX IMAGING, INC. (US) 2001-12-06 WO disclosed
EP-1112288-A1 THERMAL- AND PHOTOINITIATED RADICAL POLYMERIZATION IN THE PRESENCE OF AN ADDITION FRAGMENTATION AGENT Ciba SC Holding AG (CH) 2001-07-04 EP disclosed
EP-1032576-A1 PHOTOACTIVATABLE NITROGEN-CONTAINING BASES BASED ON $g(a)-AMMONIUM KETONES, IMINIUM KETONES OR AMIDINIUM KETONES AND ARYL BORATES Ciba SC Holding AG (CH) 2000-09-06 EP disclosed
WO-2000011041-A1 THERMAL- AND PHOTOINITIATED RADICAL POLYMERIZATION IN THE PRESENCE OF AN ADDITION FRAGMENTATION AGENT CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-03-02 WO disclosed
WO-1998038195-A1 PHOTOACTIVATABLE NITROGEN-CONTAINING BASES BASED ON α-AMMONIUM KETONES, IMINIUM KETONES OR AMIDINIUM KETONES AND ARYL BORATES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1998-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180153768-A1 MEDICAL BATHING DEVICE NOS1, NOS2, POLR1C MGLL 1136/4885TLR8 716/4885GRM2 4609/4885
US-20180116920-A1 MULTI-STEP PROCESS FOR NO PRODUCTION NOS2, NOS1, NOS3 MGLL 1058/4885TLR8 2064/4885GRM2 4502/4885
US-10813831-B2 Medical bathing device NOS1, NOS2, POLR1C MGLL 1136/4885TLR8 716/4885GRM2 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.